Evoke Wealth, LLC

SEC CIK: 0001793432
Latest filing: Aug 10, 2026

SEC filings (opens in a new tab)

ABT holding history

Abbott Laboratories in every 13F filed by Evoke Wealth, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overview All 13F holders of ABT Full Q2 2026 holdings

Shares (Q2 2026): 0; Sold out in Q2 2026
Value: $0
% of portfolio: 0.0%
Quarters held: 19; Since Q1 2021

Holdings of ABT by Evoke Wealth, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	0	$0	0.0%	−17,449−100.0%	Sold out	Holders
Q1 2026	17,449	$1.79M	<0.1%	−3,614−17.2%	Reduced	Holders
Q4 2025	21,063	$2.64M	0.1%	−1,291−5.8%	Reduced	Holders
Q3 2025	22,354	$2.99M	0.1%	−79−0.4%	Reduced	Holders
Q2 2025	22,433	$3.05M	0.1%	+3,058+15.8%	Added	Holders
Q1 2025	19,375	$2.57M	0.1%	+486+2.6%	Added	Holders
Q4 2024	18,889	$2.14M	0.1%	+2,876+18.0%	Added	Holders
Q3 2024	16,013	$1.83M	<0.1%	+16,013	New	Holders
Q2 2024	0	$0	0.0%	−15,785−100.0%	Sold out	Holders
Q1 2024	15,785	$1.79M	0.1%	+15,785	New	Holders
Q4 2023	0	$0	0.0%	−14,592−100.0%	Sold out	Holders
Q3 2023	14,592	$1.41M	<0.1%	−373−2.5%	Reduced	Holders
Q2 2023	14,965	$1.63M	0.1%	+429+3.0%	Added	Holders
Q1 2023	14,536	$1.47M	0.1%	+443+3.1%	Added	Holders
Q4 2022	14,093	$1.55M	0.1%	+550+4.1%	Added	Holders
Q3 2022	13,543	$1.31M	0.1%	+146+1.1%	Added	Holders
Q2 2022	13,397	$1.46M	0.1%	−156−1.2%	Reduced	Holders
Q1 2022	13,553	$1.60M	0.1%	−3,271−19.4%	Reduced	Holders
Q4 2021	16,824	$2.37M	0.1%	+40.0%	Added	Holders
Q3 2021	16,820	$1.99M	0.1%	−76−0.4%	Reduced	Holders
Q2 2021	16,896	$1.96M	0.1%	+4,644+37.9%	Added	Holders
Q1 2021	12,252	$1.47M	0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.